Vitae Pharmaceuticals Jumps 158% on Allergan plc Deal

Allergan plc (AGN) has agreed to buy Vitae Pharmaceuticals Inc (VTAE) for nearly $640 million

Sep 14, 2016 at 10:33 AM
facebook twitter linkedin


Shares of Vitae Pharmaceuticals Inc (NASDAQ:VTAE) have absolutely blown up, after Allergan plc Ordinary Shares (NYSE:AGN) agreed to buy the drugmaker for roughly $640 million in cash, or $21 per share. After being halted in pre-market action, VTAE is now the top percentage gainer on the Nasdaq, more than 158% higher at $20.91 -- fresh off a new annual high of $20.93 -- while AGN has advanced 2.6% at $246.45.

Suffice it to say, VTAE short sellers have gotten toasted. While some of these bears got out in the nick of time -- short interest on the stock fell nearly 10% in the latest report period -- a still-considerable 6.5% of its float is dedicated to short interest. By contrast, five of six analysts rated the shares a "strong buy" heading into today -- and traders who followed their advice are being handsomely rewarded.

The brokerage bunch has also been high on AGN. Eighty percent of analysts tracking the stock consider it worthy of a "buy" or better endorsement, with not a single "sell" opinion to be found. Likewise, options traders have been wagering on upside for the shares. AGN's 10-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) is 2.29, near the top one-fifth of all readings taken in the prior year.

That said, Allergan plc Ordinary Shares (NYSE:AGN) hasn't fared nearly as well on the charts as Vitae Pharmaceuticals Inc (NASDAQ:VTAE). Despite sharp gains this morning, the former stock has shed more than 21% year-to-date. Plus, AGN's formerly supportive 50-day moving average looks like it may be switching roles to act as resistance.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

 


 


 
Special Offers from Schaeffer's Trading Partners